Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-06-23 | 2017-12-18 | 13709 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-09-07 | 2018-03-20 | 21562 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2019-06-28 | 2019-12-24 | 87971 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2023-10-02 | 2023-12-22 | 205611 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Actual shortage | 2024-02-07 | 2024-04-29 | 218776 |
IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-07-12 | 2018-05-09 | 15521 |
IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2019-03-04 | 2019-05-29 | 77376 |
IRBESARTAN-HCTZ | 300MG 12.5MG | TABLET | Resolved | 2020-10-09 | 2020-10-30 | 126054 |
IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-06-29 | 2018-05-09 | 14365 |
IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2019-02-13 | 2019-04-25 | 75548 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
TARO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80025 |
TARO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80028 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
VAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58386 |